Commercial

Enhancing Therapeutic Alliance and promoting Shared Decision Making

December 18, 2017

The latest White Paper from the health psychology experts at Atlantis Healthcare examines how collaborative communication between healthcare professionals and their patients (the ‘therapeutic alliance’) can lead to improved patient outcomes. The paper explores the role played by pharmaceutical companies in overcoming barriers to effective patient communication during consultation and treatment. It also looks at […]

Building a Collaborative HCP-Patient Relationship: Insights from Health Psychology

December 18, 2017

Research shows that patients who have a good relationship with their HCPs are more likely to achieve better health outcomes and have greater adherence to their treatment. Dr. Kate Perry, Director of Behavioral Science at Atlantis Healthcare, provides insights on the benefits of a collaborative therapeutic alliance – why it’s important, how it evolves throughout […]

Gene Therapy Alliance in X-linked Chronic Granulomatous Disease

December 15, 2017

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has approved XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR (tofacitinib) extended release 11 mg once daily (QD) for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to […]

Acer Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

December 15, 2017

NEWTON, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, today announced the closing of the previously announced underwritten public offering of 916,667 shares of its common stock at a […]

Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries

December 15, 2017

Mechelen, Belgium; 14 December 2017; 22.01 CET – Galapagos NV (Euronext & NASDAQ: GLPG) announced today the decision to opt-in on the co-promotion of filgotinib with collaboration partner Gilead Sciences in eight European countries, should filgotinib be approved for commercial sale. Galapagos assumes 35% of the co-promotion efforts in Germany, France, Italy, Spain, the United […]

Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

December 15, 2017

New York, USA, Melbourne, Australia and Leuven, Belgium, December 15, 2017, 00:20h CET – Mesoblast Limited (ASX: MSB; Nasdaq: MESO) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) today announce that Mesoblast has granted TiGenix exclusive access to certain of its patents to support global commercialization of the adipose-derived mesenchymal stem cell product Cx601 for […]

TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany

December 15, 2017

ZUG, Switzerland, Dec. 15, 2017 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, announced today that ZEJULA® (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, is now available by prescription in Germany. ZEJULA is also currently available for patients in the United Kingdom (UK) who have private insurance. On November 16, the […]

Johnson & Johnson and the American Cancer Society Launch Cancer.com

December 14, 2017

Cancer.com provides individual content tailored to when patients need at various stages of diagnosis and treatment such as at the point of diagnosis, making treatment decisions, during treatment, remission, and the potential of facing recurrence. The drug research and development arm of Johnson & Johnson in conjunction with the American Cancer Society have rolled out […]

FDA Launches Online Tool To Help Doctors Prescribe Antibiotics

December 14, 2017

The Food and Drug Administration has launched a new website to help clinicians make more informed prescribing decisions by ensuring they have direct and timely access to information about when bacterial or fungal infections are likely to respond to a specific antibacterial or antifungal drug.   According to the Centers for Disease Control and Prevention, […]

Bumper Crop Of New Drugs Fails To Lift Big Pharma R&D Returns

December 14, 2017

LONDON (Reuters) – It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.   In fact, projected returns at 12 of the world’s top drugmakers have fallen to an eight-year […]

Rockwell Medical Signs Exclusive License Agreement with Comercializadora BioRenal SpA to Commercialize Triferic® in Chile

December 14, 2017

WIXOM, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (NASDAQ:RMTI), announced today that it has signed an exclusive license and manufacturing supply agreement with privately held BioRenal for the rights to commercialize Rockwell’s Triferic for End-Stage-Renal-Disease (ESRD) patients in Chile. Rockwell’s Triferic is the only FDA approved therapy to replace iron and maintain […]

SCORR Marketing Promotes Seven Team Members

December 14, 2017

Kearney, Neb., Dec. 14, 2017 (Business Wire) — SCORR Marketing, a global health science marketing and communications firm, has promoted seven members of its team. April Roggasch has been promoted to chief financial officer; Brook Pierce to senior director of creative services and internal marketing; Drake Sauer to art director; Carrie Whiting to human resources […]

FEEDBACK